Jerry Karabelas

(Dr. Argeris Karabelas Ph.D.)

Currently holds positions in Polyphor AG, Human Genome Sciences Inc and Bausch Health Companies Inc

Positions

Position Company Period
Chairman of the Board Polyphor AG None -
Chairman of the Board, Presiding Independent Director Human Genome Sciences Inc Oct. 17, 2004 -
Independent Director Bausch Health Companies Inc June 1, 2016 -
Chairman of the Board Polyphor AG None -
Independent Director Rocket Pharmaceuticals Inc July 1, 2012 - June 23, 2016
Independent Director Vanda Pharmaceuticals Inc Dec. 16, 2010 - Jan. 18, 2012
Jerry Karabelas's trades of Bausch Health Companies Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-02 2024-10-01
US Regenxbio Inc (RGNX)
PS Planned sale
10,000 -47.0%
10.11
USD 101,052 		10,000 -47.0% 10.11 USD 101,052
2024-09-04 2024-09-03
US Regenxbio Inc (RGNX)
PS Planned sale
700 -5.8%
12.34
USD 8,638 		700 -5.8% 12.34 USD 8,638
2024-09-04 2024-09-03
US Regenxbio Inc (RGNX)
PS Planned sale
9,300 -43.7%
11.50
USD 106,950 		9,300 -43.7% 11.50 USD 106,950
2024-08-05 2024-08-01
US Regenxbio Inc (RGNX)
PS Planned sale
100 -0.9%
15.00
USD 1,500 		100 -0.9% 15.00 USD 1,500
2024-08-05 2024-08-01
US Regenxbio Inc (RGNX)
PS Planned sale
400 -3.4%
14.59
USD 5,834 		400 -3.4% 14.59 USD 5,834
2024-08-05 2024-08-01
US Regenxbio Inc (RGNX)
PS Planned sale
9,600 -44.9%
13.45
USD 129,120 		9,600 -44.9% 13.45 USD 129,120
2024-07-30 2024-07-29
US Regenxbio Inc (RGNX)
PS Planned sale
11,000 -49.4%
15.05
USD 165,495 		11,000 -49.4% 15.05 USD 165,495
2024-07-03 2024-07-01
US Regenxbio Inc (RGNX)
PS Planned sale
10,000 -47.0%
11.27
USD 112,691 		10,000 -47.0% 11.27 USD 112,691
2016-08-12 2016-08-11
B Purchase
4,000 +23.9%
24.65
USD 98,600 		4,000 +23.9% 24.65 USD 98,600
2015-02-25 2015-02-23
B Purchase
603,832 +36.1%
6.00
USD 3,622,992 		603,832 +36.1% 6.00 USD 3,622,992
// ... existing code ... // ... rest of the file ...